Ionis Pharmaceuticals, Inc. (IONS) financial statements (2021 and earlier)

Company profile

Business Address 2855 GAZELLE COURT
CARLSBAD, CA 92010
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,8922,5002,0841,023665779729
Cash and cash equivalents39868327913085129143
Short-term investments1,4951,8161,805893581650586
Receivables   63108114
Inventory, net of allowances, customer advances and progress billings22189    
Inventory22189    
Contract with customer, asset766313
Other current assets14014010272151516
Other undisclosed current assets   10103288
Total current assets:2,1312,7212,2081,168798837837
Noncurrent Assets
Property, plant and equipment181154132122939089
Intangible assets, net (including goodwill)28262422   
Intangible assets, net (excluding goodwill)28262422   
Deferred income tax assets 306
Other noncurrent assets50281310   
Deferred tax assets, net291    
Other undisclosed noncurrent assets    222930
Total noncurrent assets:259513460154115119119
TOTAL ASSETS:2,3903,2332,6681,322912956956
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities174153106117817361
Accounts payable17162925212818
Accrued liabilities90674867362830
Employee-related liabilities66372925241612
Taxes payable133     
Deferred revenue108118
Debt3002142113
Deferred revenue and credits106516752
Contract with customer, liability160
Other undisclosed current liabilities     9 
Total current liabilities:583273280225134149115
Noncurrent Liabilities
Long-term debt and lease obligation, including:53960628593   
Long-term debt, excluding current maturities6060628593   
Other undisclosed long-term debt and lease obligation479      
Liabilities, other than long-term debt4244905677391134128
Deferred revenue and credits7391134128
Deferred revenue424490
Contract with customer, liability567
Other undisclosed noncurrent liabilities 726513588472455
Total noncurrent liabilities:9631,2761,200679679606583
Total liabilities:1,5461,5491,481903813755698
Stockholders' equity
Stockholders' equity attributable to parent8431,4711,048331100201258
Common stock0000000
Additional paid in capital2,1142,2042,0471,5501,3111,3091,225
Accumulated other comprehensive income (loss)(21)(25)(32)(32)(30)(14)40
Accumulated deficit(1,249)(708)(967)(1,187)(1,181)(1,095)(1,007)
Stockholders' equity attributable to noncontrolling interest 21313988   
Total stockholders' equity:8431,6851,187419100201258
TOTAL LIABILITIES AND EQUITY:2,3903,2332,6681,322912956956

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues7291,123600508347284214
Revenue, net113   
Cost of revenue(12)(4)(2)    
Cost of goods and services sold(12)(4)(2)    
Gross profit:7171,118598508347284214
Operating expenses(889)(752)(661)(483)(393)(359)(262)
Other undisclosed operating income  2    
Operating income (loss):(172)366(61)25(46)(76)(48)
Nonoperating income47523045424
Investment income, nonoperating47523085424
Other nonoperating expense(0)(1)(0)(4)   
Interest and debt expense(45)(71)(45)(45)(43)(37)(31)
Other undisclosed loss from continuing operations before equity method investments, income taxes   (7)   
Income (loss) from continuing operations before equity method investments, income taxes:(170)347(76)(23)(84)(108)(54)
Other undisclosed income from continuing operations before income taxes    020 
Income (loss) from continuing operations before income taxes:(170)347(76)(23)(84)(88)(54)
Income tax expense (benefit)(317)(44)2916(3)(0)15
Net income (loss):(487)303215(17)(87)(88)(39)
Net income (loss) attributable to noncontrolling interest35(9)5911   
Net income (loss) attributable to parent:(451)294274(6)(87)(88)(39)
Other undisclosed net income (loss) available to common stockholders, basic(0)2316   
Net income (loss) available to common stockholders, diluted:(451)29727710(87)(88)(39)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(487)303215(17)(87)(88)(39)
Other comprehensive income (loss)47(0)(1)   
Comprehensive income (loss):(483)310215(19)(87)(88)(39)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest35(9)5911   
Other undisclosed comprehensive income (loss), net of tax, attributable to parent    (17)(53)19
Comprehensive income (loss), net of tax, attributable to parent:(447)301274(7)(103)(142)(20)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: